TLIS
Talis Biomedical Corporation Common Stock
TLIS
TLIS
Delisted
TLIS was delisted on the 30th of August, 2024.
35 hedge funds and large institutions have $12.1M invested in Talis Biomedical Corporation Common Stock in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 17 reducing their positions, and 15 closing their positions.
Holders
35
Holders Change
-9
Holders Change %
-20.45%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
5
Reduced
17
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
NM
1
Newtyn Management
New York
|
$231K |
| 2 |
2
Millennium Management
New York
|
$164K |
| 3 |
3
Renaissance Technologies
New York
|
$88K |
| 4 |
E
4
Ergoteles
New York
|
$56K |
| 5 |
5
Mercer Global Advisors
Denver,
Colorado
|
$65K |
